What Innovative Pharma Solutions, Inc. does

Innovative Pharma Solutions, Inc. (IPS) is a US-based private pharmaceutical services company headquartered in North Wales/Philadelphia, PA that provides workforce enhancement, business process outsourcing, and outsourced drug development services to pharmaceutical, biotechnology, medical device, consumer products, government/defense, and specialty chemical clients. The company markets a broad portfolio of services spanning People Solutions (BPO/MSP and talent acquisition), Technical Interviewing, Agentic AI for drug discovery and talent evaluation, Pre-Clinical and Drug Development (fully integrated IND programs), Biologics and Gene Therapy, Antibody-Drug Conjugates, Formulation, Toxicology, API and Raw Material Sourcing, Custom Synthesis and Manufacturing, Clinical Functional Services, Medical Device and MedTech consulting, Strategic Sourcing, Outsourcing, Government services, Venture Capital support, and Consulting. Its IPS Laboratories subsidiary offers Build-to-Suit dedicated laboratory facilities with cradle-to-grave lifecycle management.

Underlying technology combines what IPS describes as Agentic AI stacks for drug discovery (custom systems designed for raw scientific data processing, causal reasoning, and bias reduction) with a conventional statistical and analytics stack (SPSS, SAS, MATLAB, R, SQL, Python, Oracle BI, Power BI, Tableau), all hosted under DOD-level security infrastructure on US-based servers. Operations rely on a global network of audited suppliers for API and raw material sourcing, FDA-inspected sites for toxicology and manufacturing, and subject matter experts with an average of 20+ years of industry experience. The company claims 40+ commercial drug launches, 5 NDA filings in the past 5 years, a 1:1.1 submission-to-hire ratio in recruiting, and a 200% reduction in overhead costs via its Perma-Flex engagement model.

Revenue is generated primarily through managed services contracts, professional services fees, and custom manufacturing engagements with enterprise clients across five primary verticals plus government and VC. The company is privately held under founder/CEO Steven W. Choi with no disclosed funding rounds, no institutional investor backing, and no public revenue figures. It is NMSDC-certified as a Minority Business Enterprise, holds an EcoVadis Bronze sustainability rating, and maintains ISO 13485:2016, ISO 14971, 21 CFR Part 820, and cGMP manufacturing certifications.

Name

Innovative Pharma Solutions, Inc.

Legal name

Innovative Pharma Solutions, Inc.

Website

https://ipsiweb.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

IPS is a US-based private pharmaceutical services firm providing workforce solutions, technical interviewing, agentic AI-enabled drug discovery, and outsourced drug development and manufacturing services to pharma, biotech, medical device, consumer products, government, and specialty chemical clients.

Ownership category

akta.pro rank

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)

akta.pro secondary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical staffing services
• Drug development consulting
• Contract manufacturing services
• Biologics development services
• Technical recruiting services

Headquarters

HQ city

North Wales

HQ country

United States

HQ region

North America

Offices1 record

Markets served

Revenue model

1. People Solutions and BPO Services: Business Process Outsourcing providing workforce enhancements through flexible business models. Includes talent acquisition, managed services, and technical interviewing as standalone or bundled services. Revenue generated through managed service contracts and staffing fees.
2. Outsourcing Services: Complete managed outsourcing solutions for drug and consumer development and manufacturing. Full contract manufacturing outsourcing with strategic alliances providing best value for manufacturing services. Revenue from long-term outsourcing contracts.
3. Consulting Services: Expert consulting for business process, clinical programs, and scientific/technical domains. GAP Analysis services for efficiency, cost avoidance, and cost reduction. Revenue from consulting engagement fees.
4. API and Raw Materials Sourcing: API synthesis, raw material sourcing, and bench to commercial scale custom manufacturing through a global network of audited suppliers. Fixed cost and managed deliverable timing with project management services.
5. Drug Discovery and Development Services: Fully-integrated IND program services from discovery through clinical trials and market launch. Manufacturing services for small molecules and biologics including cGMP development, formulation, and commercialization support.
6. Technical Interviewing Services: Standalone technical interviewing service providing deep, role-specific candidate assessments. Reduces burden on HR teams and hiring managers with expert interviewers evaluating technical skills and performance under pressure.
7. Venture Capital Services: Supporting entrepreneurs and institutional investors with venture capital expertise including seed funding, angel investments, and series raises. Evaluation and due diligence services for capital firms.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Innovative Pharma Solutions provides workforce enhancements, Business Process Outsourcing (BPO), Managed Service Provider (MSP), and specialized staffing solutions to pharmaceutical, biotech, consumer products, medical device, and specialty chemical companies. The company extends into drug discovery, pre-clinical and clinical development, biologics and ADC manufacturing, formulation, API/raw material sourcing, technical interviewing, and dedicated build-to-suit laboratory facilities through its IPS Laboratories subsidiary.

Product overview

Innovative Pharma Solutions (IPS) operates as a comprehensive pharmaceutical services platform offering integrated workforce and business solutions across the drug development lifecycle. The portfolio centers on core services including People Solutions (workforce enhancement through BPO and talent acquisition), Agentic AI and The Human Element (human-centered AI systems for drug discovery and talent evaluation), and Pre-Clinical and Drug Development (fully-integrated IND programs). Manufacturing capabilities span API and Raw Materials Sourcing, Custom Synthesis and Manufacturing, Biologics and Gene Therapy, ADC development, and Formulation Services. IPS Laboratories provides dedicated build-to-suit facilities for cradle-to-grave drug lifecycle management. Supporting services include Clinical FSP, Medical Devices and Medtech consulting, Strategic Sourcing, Outsourcing, Diversity Aggregation Program (DAP), Government Services, Venture Capital, Consulting, and Technology and Data Security. The architecture combines a unified service platform with specialized modules for small molecules, biologics, medical devices, and talent solutions.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 200% reduction in overhead costs using Perma-Flex Models
• +5 more outcomes

Segments7 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

One partnership is on record.

• Eastern Minority Supplier Development Council (EMSDC)coreStrategic or Co-development PartnerEMSDC supports IPS's Diversity Aggregation Program (DAP) by providing access to a network of carefully selected diverse suppliers. The partnership enables IPS to offer enhanced visibility to diverse organizations while helping clients meet DEI goals.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Alcami Corporation: Smaller-scale US CDMO offering drug substance, drug product, and analytical services for pharma/biotech — most directly comparable to IPS by size, capabilities, and US-based delivery model.
• ICON plc: Clinical CRO with broad biotech/pharma services. Overlaps with IPS Clinical FSP and pre-clinical drug development offerings for pharmaceutical and biotech customers.
• IQVIA: Global CRO and clinical/technology services provider. Comparable to IPS through clinical FSP, biotech/pharma R&D support, and analytics/AI-enabled services for life sciences sponsors.
• Medpace: Mid-sized clinical CRO serving biotech and pharma. Comparable to IPS's clinical FSP and life-sciences services portfolio.
• WuXi AppTec: Global CRO/CDMO providing discovery, biologics, and testing services for pharma/biotech — closely aligned with IPS's pre-clinical development, biologics/ADC, and formulation services.
• Catalent: CDMO with biologics, ADC fill-finish, and formulation capabilities. Direct comparability to IPS's drug product manufacturing, biologics, ADC, and formulation services.
• Charles River Laboratories: Large CRO/CDMO offering drug discovery, preclinical, and biologics manufacturing services — overlapping with IPS's pre-clinical, biologics, ADC, and formulation offerings to pharma/biotech sponsors.
• Parexel International: Global CRO with deep clinical and regulatory services for pharma/biotech. Comparable to IPS's clinical FSP, consulting, and CMC/regulatory support offerings.

Broad incumbents

• Lonza Group: Largest pure-play CDMO with biologics and cell/gene therapy manufacturing at scale. Comparable to IPS's biologics, ADC, and formulation offerings but at a much larger scale and broader portfolio.
• Thermo Fisher Scientific (CDMO/CRO): Through Patheon and PPD, offers integrated pharma services from development through commercial manufacturing. Overlaps broadly with IPS's CRO/CDMO and analytical/quality services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/innovative-pharma-solutions-inc.

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovative Pharma Solutions, Inc.